Orange Book product · Generic (ANDA)
LEVOMILNACIPRAN HYDROCHLORIDE
LEVOMILNACIPRAN HYDROCHLORIDE
Generic (ANDA)ANDA 210771TE ABRX PRINSTON INC
At a glance
Mar 20, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 20, 2023
3 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOMILNACIPRAN HYDROCHLORIDE
Strength
EQ 20MG BASE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 210771
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOMILNACIPRAN HYDROCHLORIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
